Breaking News, Collaborations & Alliances

Pluristyx and Accelerated Biosciences Enter Clinical Manufacturing Partnership

CDMO Pluristyx to make clinical grade human trophoblast stem cells (hTSCs) banks.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pluristyx, an advanced therapy tools and services biotechnology company, and Accelerated Biosciences, a regenerative medicine innovator in the use of proprietary human trophoblast stem cells (hTSCs), signed an agreement for Pluristyx to manufacture clinical grade hTSC banks under Good Manufacturing Practices (GMP). Accelerated Biosciences will use and make these stem cell banks available to commercial partners for further manufacturing of advanced biologic and cellular therapies. hTSCs have uniq...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters